Brief: Mezzion Pharma Says Cancels 4.4 Bln Won Worth Of Its Treasury Shares
Dec 13 (Reuters) - Mezzion Pharma Co Ltd 140410.KQ :
* SAYS CANCELS 4.4 BILLION WON ($3.92 million) WORTH OF ITS
TREASURY SHARES
Source text for Eikon: https://bit.ly/2SEykjO
Further company coverage: 140410.KQ
($1 = 1,121.6000 won)
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on Mezzion Pharma
See all newsBrief: Mezzion Secures Strategic Financing To Support Advancement Of Global Phase 3 Fuel-2 Trial In Fontan Patients
Brief: Mezzion Reports Pre-Ind FDA Feedback On The Development Of Udenafil In Adpkd
Brief: Mezzion Pharmaceuticals Appoints Ridwan Shabsigh As President & Chief Operating Officer
Brief: Mezzion Pharmaceuticals Reaches Key Enrollment Milestone In World's Largest Fontan Clinical Trial
Brief: Mezzion Pharmaceuticals Announces Dr Rahul Rathod As Global Principal Investigator For The Confirmatory Pivotal Phase 3 Trial FUEL-2